GENTA INCORPORATED Berkeley Heights, NJ 07922Stock Option Agreement • March 17th, 2008 • Genta Inc De/ • Biological products, (no disgnostic substances) • New York
We are pleased that you are willing to continue to serve as Chief Executive Officer, and Chairman of the Board of Directors (the “Board”), of Genta Incorporated, a Delaware corporation (together with its successors and assigns, the “Company”). Accordingly, we would like to offer you continued employment on the terms set forth in this amended and restated letter agreement dated November 30, 2007 (this “Agreement”), which upon countersignature by you shall become a binding agreement between you and the Company (each, a “Party”).
PROJECT CONTRACTProject Contract • March 17th, 2008 • Genta Inc De/ • Biological products, (no disgnostic substances)
This Project Contract dated 01 June 2007 (“Effective Date”) is issued pursuant to the Master Agreement dated 12 December 2003 between Genta, Inc. (“GENTA”) and ICON Clinical Research, L.P. (“ICON”). Except as modified by this Project Contract, the terms and conditions of the Agreement are incorporated herein by reference and shall govern the performance of the parties’ duties under this Project Contract. Capitalized terms used herein and not otherwise defined are used as defined in the Master Agreement.
